logo
  • Home
  • About Us
    • About Us
    • Why Raglan
    • Careers
  • Selected Transactions
  • Raglan IPO Projects
    • Raglan Pharmaceutical & Life Science Projects
    • Raglan Natural Resources
  • News
  • Contact us
  • Search

2018

Amryt Pharma – Update On Ongoing AP101 Trial

Amryt

by lynchski

Amryt Pharma – Grant Funding From Irish Government For AP103

Amryt

by lynchski

Amryt Pharma – LOJUXTA To Be Reimbursed In France

Amryt

by lynchski

Amryt Pharma – Interim Results

Amryt

by lynchski

Amryt Pharma - Amryt Receives Ind Approval From FDA for AP101

Amryt

by lynchski

Amryt Pharma – FDA Grants Pediatric Rare Disease Designation

Amryt

by lynchski

Amryt Pharma – Trading Update & Significant Momentum Building

Amryt

by lynchski

Amryt Pharma - NHS England Approves Funding For LOJUXTA

Amryt

by lynchski

County Mayo Solo Sailor Joan Mulloy Qualifies for Route du Rhum Race

Count

by lynchski

Amryt Pharma - Four Middle East LOJUXTA® Distribution Agreements

Amryt

by lynchski

  • 1
  • 2
  • 3
© 2021 Raglan Capital. All rights reserved

Privacy Preference Center

Privacy Preferences